Search - tctmd.com

Displaying 621 - 640 of 764

Sort: Relevancy | Date

News Daily News

El Xience V No es Inferior al Cypher en PCI Primarias

July 24, 2012

News Daily News

Un Registro Japonés Confirma que tanto la PCI como la CABG son ‘Parecidas’ contra la Enfermedad de Tronco Coronario Izquierdo de Complejidad Baja o Moderada

Caitlin E. Cox

June 28, 2012

News Daily News

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Caitlin E. Cox

June 28, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Daily News

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Leah Lawrence

June 15, 2012

Presentation

Stent Thrombosis with Everolimus-Eluting Stents

Presenter: T. Palmerini

June 14, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

News Daily News

Meta Análisis: Superior Eficacia de los SLF sin poner en Peligro la Seguridad

May 22, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Industry News

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

May 18, 2012

Presentation EuroPCR 2012

A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial

Presenter: 13956|Raul Moreno

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

Presentation EuroPCR 2012

Three-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

News Industry News

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

May 15, 2012

Presentation TCT Mediterranean 2012

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Presenter: C. Moretti

May 04, 2012

Presentation TCT Russia 2012

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Presenter: Gregg W. Stone

April 26, 2012

Advertisement

El Xience V No es Inferior al Cypher en PCI Primarias

Un Registro Japonés Confirma que tanto la PCI como la CABG son ‘Parecidas’ contra la Enfermedad de Tronco Coronario Izquierdo de Complejidad Baja o Moderada

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Meta Análisis: Menor Trombosis del Stent a los 2 Años con SLE que con Otro Tipo de SLF

Stent Thrombosis with Everolimus-Eluting Stents

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

Meta Análisis: Superior Eficacia de los SLF sin poner en Peligro la Seguridad

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

PROMUS Element™ Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Three-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content